Navigation Links
DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
Date:1/30/2013

Dallas, TX (PRWEB) January 30, 2013

The patient advocates at DrugRisk.com are alerting those taking the blood thinner Pradaxa of new information added to the site which shows the judge presiding over the ongoing internal bleeding lawsuits has ordered the drug maker to disclose information on prior fraud charges.

The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. “In many cases, patients follow litigation to learn more about a drug they’re taking and what questions to ask their doctor,” explains DrugRisk representative Ryan Mayer.

The resource center previously added a report from the Institute for Safe Medication Practices which ranked anticoagulants like Pradaxa among the highest risk outpatient drugs. The Institute also found that hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.*

Reports show that experts still disagree about the safety of Pradaxa and its bleeding risks. While there has been no official Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.** However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.***

DrugRisk has learned that, due to the number of patients filing a Pradaxa lawsuit, they are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, the resource center has learned that, Judge Herndon, who is overseeing the Pradaxa litigation, signed an order on January 19th denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.****

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Instutute for Safe Medication Practices, 1/9/13; http://ismp.org/quarterwatch/pdfs/2012Q2.pdf
** http://fda.gov/Drugs/DrugSafety/ucm326580.htm
*** http://content.onlinejacc.org/article.aspx?articleid=1206384
**** http://www.ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2251290.0.pdf#search=%22pradaxa%22

Read the full story at http://www.prweb.com/releases/pradaxa-litigation/pradaxa-recalled/prweb10355992.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
2. DrugRisk Announces New Pradaxa Health Warning From Australia
3. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
4. DrugRisk Announces Updated Information on Mirena Lawsuits
5. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
6. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
7. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
8. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
9. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
10. New Transvaginal Mesh Lawsuit in American Medical Systems Pelvic Mesh Litigation filed by Wright & Schulte LLP is Underway in West Virginia Federal Court
11. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: